Published in Clin Neurophysiol on February 23, 2010
Quantitative EEG for the detection of brain ischemia. Crit Care (2012) 1.19
A quantitative EEG method for detecting post clamp changes during carotid endarterectomy. J Clin Monit Comput (2011) 0.80
Perturbation of Brain Oscillations after Ischemic Stroke: A Potential Biomarker for Post-Stroke Function and Therapy. Int J Mol Sci (2015) 0.75
Quantitative EEG and cerebral ischemia. Clin Neurophysiol (2010) 0.75
Identifying Dysfunctional Cortex: Dissociable Effects of Stroke and Aging on Resting State Dynamics in MEG and fMRI. Front Aging Neurosci (2016) 0.75
Integrated treatment modality of cathodal-transcranial direct current stimulation with peripheral sensory stimulation affords neuroprotection in a rat stroke model. Neurophotonics (2017) 0.75
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature (2006) 9.31
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
On the use of scaling and clustering in the study of semantic deficits. Neuropsychology (2003) 5.38
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol (2011) 5.01
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol (2009) 2.83
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet (2005) 2.08
Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol (2010) 1.95
Cerebellar neurocognition: insights into the bottom of the brain. Clin Neurol Neurosurg (2008) 1.83
Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res (2006) 1.70
SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum Mutat (2008) 1.59
The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease. Int J Geriatr Psychiatry (2005) 1.56
Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet (2006) 1.55
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain (2011) 1.46
Monitoring of physical activity after stroke: a systematic review of accelerometry-based measures. Arch Phys Med Rehabil (2010) 1.45
CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. Hum Mol Genet (2003) 1.43
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol (2007) 1.42
Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet (2004) 1.37
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain (2006) 1.36
Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci (2003) 1.36
Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS). Brain Res (2008) 1.35
LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet (2003) 1.32
Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging (2008) 1.31
Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol Aging (2013) 1.30
Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol Ther (2009) 1.23
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat (2007) 1.20
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet (2007) 1.20
Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain (2006) 1.16
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa. Mov Disord (2006) 1.13
Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. Mol Genet Metab (2007) 1.11
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Hum Mutat (2009) 1.11
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Mov Disord (2007) 1.11
Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin Chem (2009) 1.10
Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener (2012) 1.08
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Intracranial pressure fluctuations: a potential risk factor for glaucoma? Acta Ophthalmol (2013) 1.08
APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Hum Mutat (2009) 1.07
A diffusion tensor imaging group study of the spinal cord in multiple sclerosis patients with and without T2 spinal cord lesions. J Magn Reson Imaging (2009) 1.05
No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging (2009) 1.05
Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiol Aging (2006) 1.04
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. JAMA Neurol (2013) 1.04
Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J (2012) 1.03
Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice. J Pathol (2012) 1.03
A role for the cerebellum in motor speech planning: evidence from foreign accent syndrome. Clin Neurol Neurosurg (2005) 1.03
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol (2011) 1.01
Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Hum Mol Genet (2005) 1.01
Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry (2005) 1.01
Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review. Cortex (2010) 1.00
A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurol (2006) 1.00
C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2013) 1.00
Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochem Int (2006) 0.99
Cognitive and affective disturbances following focal cerebellar damage in adults: a neuropsychological and SPECT study. Cortex (2009) 0.99
Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome. Clin Chem Lab Med (2010) 0.99
Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model. Behav Brain Res (2012) 0.96
Cognitive, linguistic and affective disturbances following a right superior cerebellar artery infarction: a case study. Cortex (2008) 0.96
Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association. J Alzheimers Dis (2010) 0.96
No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum Mutat (2009) 0.96
Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia. Hum Mutat (2009) 0.96
Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiol Aging (2013) 0.95
Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiol Aging (2011) 0.95
Correlation of cognitive dysfunction and diffusion tensor MRI measures in patients with mild and moderate multiple sclerosis. J Magn Reson Imaging (2010) 0.95
Reproducibility and clinical relevance of quantitative EEG parameters in cerebral ischemia: a basic approach. Clin Neurophysiol (2009) 0.95
Pathophysiology of language switching and mixing in an early bilingual child with subcortical aphasia. Neurocase (2005) 0.94
Assessing fatigue in multiple sclerosis: Dutch modified fatigue impact scale. Acta Neurol Belg (2003) 0.94
Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. Mol Genet Metab (2013) 0.94
Dimerization and DNA binding properties of the Bacillus licheniformis 749/I BlaI repressor. J Biol Chem (2003) 0.94
Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P). Neurochem Int (2009) 0.93
Posterior fossa syndrome after a vermian stroke: a new case and review of the literature. Pediatr Neurosurg (2007) 0.93
The cerebellum and language: the story so far. Folia Phoniatr Logop (2007) 0.93
Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics (2007) 0.92
Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration. J Neurosci (2008) 0.92
Long-term cognitive deficits following posterior fossa tumor resection: a neuropsychological and functional neuroimaging follow-up study. Neuropsychology (2009) 0.92
Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia. Mol Genet Metab (2010) 0.91
Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans. J Appl Physiol (1985) (2004) 0.91
Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol (2010) 0.91
The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochem Res (2010) 0.90
Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathol Commun (2013) 0.90
Mechanical energy in toddler gait. A trade-off between economy and stability? J Exp Biol (2004) 0.90
Postoperative motor speech production in children with the syndrome of 'cerebellar' mutism and subsequent dysarthria: a critical review of the literature. Eur J Paediatr Neurol (2007) 0.90
No correlation between time-linked plasma and CSF Abeta levels. Neurochem Int (2009) 0.90
Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults. Int J Geriatr Psychiatry (2012) 0.89
Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation (2013) 0.87
Posterior fossa syndrome in adults: a new case and comprehensive survey of the literature. Cortex (2011) 0.87
Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. Clin Chim Acta (2008) 0.87
Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint. Neurobiol Aging (2008) 0.87
A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain (2007) 0.87